LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
Podcasts & Webcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
BioCentury-BayHelix China Healthcare Summit
East-West Healthcare Reception
BioCentury-BayHelix East-West Summit
Bio€quity Europe
BioCentury Grand Rounds Inquiry
Grand Rounds U.S.
Grand Rounds Europe
The BioCentury Show
Webinars - Upcoming & On-Demand
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a target name.
REQUEST A FREE TRIAL
Pipeline
Deals
Financings
Articles
BioCentury
|
Nov 23, 2022
Data Byte
Translational spotlight on East-West innovation
Collaborations between investigators at Asian and Western universities in BioCentury’s Distillery present licensing and partnering opportunities
Read More
BioCentury
|
Oct 7, 2022
Distillery Therapeutics
Overexpressing ANXA2 or MPP1 for glaucoma
Read More
BioCentury
|
Jun 2, 2022
Distillery Therapeutics
Glycolysis-activating small molecule cocktail for myocardial infarction
Read More
BioCentury
|
Jul 29, 2021
Distillery Therapeutics
PTEN mRNA nanoparticles increase sensitivity to cancer immunotherapy
DISEASE CATEGORY: Cancer
INDICATION: Melanoma; prostate cancer Restoring the expression of the tumor suppressor PTEN via nanoparticle delivery of PTEN mRNA could enhance the efficacy of
Read More
BioCentury
|
Jun 23, 2020
Product Development
June 22 Quick Takes: Invitae acquiring ArcherDX; plus lymphoma approval for Karyopharm, Merck, Nabriva, Myovant, Assembly-AbbVie, Genentech and more
Read More
BioCentury
|
Oct 24, 2019
Preclinical News
Oct. 24 Preclinical Quick Takes: anti-neuraminidase human antibodies for broad flu protection; plus Ionis-Baylor, Merck and more
Read More
BioCentury
|
Apr 22, 2019
Distillery Therapeutics
The former diabetes drug phenformin for T cell ALL
Read More
BioCentury
|
Jan 4, 2019
Tools & Techniques
Making AD mice as diverse as patients
How adding genetic diversity to Alzheimer’s mice could help define responders
Read More
BioCentury
|
Dec 11, 2018
Distillery Therapeutics
Cancer
Read More
BioCentury
|
Oct 31, 2018
Distillery Therapeutics
Cancer
Read More
Items per page:
10
1 - 10 of 120